カテゴリー： Market Monitor Global, 世界, 医療/バイオ

低分子標的薬の世界市場見通し2023年-2029年

◆英語タイトル：Targeted Small Molecule Drug Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8695 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：103 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Targeted Small Molecule Drug Market 調査レポートは次の情報を含め、グローバルにおけるの低分子標的薬市場規模と予測を収録しています。・世界の低分子標的薬市場：売上、2018年-2023年、2024年-2029年
・世界の低分子標的薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の低分子標的薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ソラフェニブ」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

低分子標的薬のグローバル主要企業は、Bayer、 Eisai、 Zelgen、 Cipla、 Natco Pharma、 AstraZeneca、 Novartis、 Roche、 Bristol-Myers Squibb、 Pfizer、 BEACON Pharma、 Jiangxi Shanxiang、 Yao Pharma、 CSPC、 CHIATAI Tianqing、 Simcereなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、低分子標的薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の低分子標的薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の低分子標的薬市場：タイプ別市場シェア、2022年
・ソラフェニブ、レンバチニブ、レゴラフェニブ、オシメルチニブ、アンロチニブ、アレクチニブ、その他

世界の低分子標的薬市場：用途別、2018年-2023年、2024年-2029年
世界の低分子標的薬市場：用途別市場シェア、2022年
・病院、小売薬局、その他

世界の低分子標的薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の低分子標的薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における低分子標的薬のグローバル売上、2018年-2023年
・主要企業における低分子標的薬のグローバル売上シェア、2022年
・主要企業における低分子標的薬のグローバル販売量、2018年-2023年
・主要企業における低分子標的薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bayer、 Eisai、 Zelgen、 Cipla、 Natco Pharma、 AstraZeneca、 Novartis、 Roche、 Bristol-Myers Squibb、 Pfizer、 BEACON Pharma、 Jiangxi Shanxiang、 Yao Pharma、 CSPC、 CHIATAI Tianqing、 Simcere

*************************************************************

・調査・分析レポートの概要
低分子標的薬市場の定義
市場セグメント
世界の低分子標的薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の低分子標的薬市場規模
世界の低分子標的薬市場規模：2022年 VS 2029年
世界の低分子標的薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの低分子標的薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の低分子標的薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ソラフェニブ、レンバチニブ、レゴラフェニブ、オシメルチニブ、アンロチニブ、アレクチニブ、その他
低分子標的薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、小売薬局、その他
低分子標的薬の用途別グローバル売上・予測

・地域別市場分析
地域別低分子標的薬市場規模 2022年と2029年
地域別低分子標的薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer、 Eisai、 Zelgen、 Cipla、 Natco Pharma、 AstraZeneca、 Novartis、 Roche、 Bristol-Myers Squibb、 Pfizer、 BEACON Pharma、 Jiangxi Shanxiang、 Yao Pharma、 CSPC、 CHIATAI Tianqing、 Simcere
...

Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
This report aims to provide a comprehensive presentation of the global market for Targeted Small Molecule Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Small Molecule Drug. This report contains market size and forecasts of Targeted Small Molecule Drug in global, including the following market information:
Global Targeted Small Molecule Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Targeted Small Molecule Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sorafenib Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Targeted Small Molecule Drug include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Targeted Small Molecule Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Small Molecule Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Targeted Small Molecule Drug Market Segment Percentages, by Type, 2022 (%)
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Global Targeted Small Molecule Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Targeted Small Molecule Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Targeted Small Molecule Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Targeted Small Molecule Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Small Molecule Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Targeted Small Molecule Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeted Small Molecule Drug, market overview.
Chapter 2: Global Targeted Small Molecule Drug market size in revenue.
Chapter 3: Detailed analysis of Targeted Small Molecule Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeted Small Molecule Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Targeted Small Molecule Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Small Molecule Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Small Molecule Drug Overall Market Size
2.1 Global Targeted Small Molecule Drug Market Size: 2022 VS 2029
2.2 Global Targeted Small Molecule Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Small Molecule Drug Players in Global Market
3.2 Top Global Targeted Small Molecule Drug Companies Ranked by Revenue
3.3 Global Targeted Small Molecule Drug Revenue by Companies
3.4 Top 3 and Top 5 Targeted Small Molecule Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Targeted Small Molecule Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Small Molecule Drug Players in Global Market
3.6.1 List of Global Tier 1 Targeted Small Molecule Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Small Molecule Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Targeted Small Molecule Drug Market Size Markets, 2022 & 2029
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type – Global Targeted Small Molecule Drug Revenue & Forecasts
4.2.1 By Type – Global Targeted Small Molecule Drug Revenue, 2018-2023
4.2.2 By Type – Global Targeted Small Molecule Drug Revenue, 2024-2029
4.2.3 By Type – Global Targeted Small Molecule Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Targeted Small Molecule Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application – Global Targeted Small Molecule Drug Revenue & Forecasts
5.2.1 By Application – Global Targeted Small Molecule Drug Revenue, 2018-2023
5.2.2 By Application – Global Targeted Small Molecule Drug Revenue, 2024-2029
5.2.3 By Application – Global Targeted Small Molecule Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Targeted Small Molecule Drug Market Size, 2022 & 2029
6.2 By Region – Global Targeted Small Molecule Drug Revenue & Forecasts
6.2.1 By Region – Global Targeted Small Molecule Drug Revenue, 2018-2023
6.2.2 By Region – Global Targeted Small Molecule Drug Revenue, 2024-2029
6.2.3 By Region – Global Targeted Small Molecule Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Targeted Small Molecule Drug Revenue, 2018-2029
6.3.2 US Targeted Small Molecule Drug Market Size, 2018-2029
6.3.3 Canada Targeted Small Molecule Drug Market Size, 2018-2029
6.3.4 Mexico Targeted Small Molecule Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Targeted Small Molecule Drug Revenue, 2018-2029
6.4.2 Germany Targeted Small Molecule Drug Market Size, 2018-2029
6.4.3 France Targeted Small Molecule Drug Market Size, 2018-2029
6.4.4 U.K. Targeted Small Molecule Drug Market Size, 2018-2029
6.4.5 Italy Targeted Small Molecule Drug Market Size, 2018-2029
6.4.6 Russia Targeted Small Molecule Drug Market Size, 2018-2029
6.4.7 Nordic Countries Targeted Small Molecule Drug Market Size, 2018-2029
6.4.8 Benelux Targeted Small Molecule Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Targeted Small Molecule Drug Revenue, 2018-2029
6.5.2 China Targeted Small Molecule Drug Market Size, 2018-2029
6.5.3 Japan Targeted Small Molecule Drug Market Size, 2018-2029
6.5.4 South Korea Targeted Small Molecule Drug Market Size, 2018-2029
6.5.5 Southeast Asia Targeted Small Molecule Drug Market Size, 2018-2029
6.5.6 India Targeted Small Molecule Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Targeted Small Molecule Drug Revenue, 2018-2029
6.6.2 Brazil Targeted Small Molecule Drug Market Size, 2018-2029
6.6.3 Argentina Targeted Small Molecule Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Targeted Small Molecule Drug Revenue, 2018-2029
6.7.2 Turkey Targeted Small Molecule Drug Market Size, 2018-2029
6.7.3 Israel Targeted Small Molecule Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Targeted Small Molecule Drug Market Size, 2018-2029
6.7.5 UAE Targeted Small Molecule Drug Market Size, 2018-2029
7 Targeted Small Molecule Drug Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Targeted Small Molecule Drug Major Product Offerings
7.1.4 Bayer Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Targeted Small Molecule Drug Major Product Offerings
7.2.4 Eisai Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Zelgen
7.3.1 Zelgen Company Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Targeted Small Molecule Drug Major Product Offerings
7.3.4 Zelgen Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Targeted Small Molecule Drug Major Product Offerings
7.4.4 Cipla Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Natco Pharma
7.5.1 Natco Pharma Company Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Targeted Small Molecule Drug Major Product Offerings
7.5.4 Natco Pharma Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Targeted Small Molecule Drug Major Product Offerings
7.6.4 AstraZeneca Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Targeted Small Molecule Drug Major Product Offerings
7.7.4 Novartis Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Targeted Small Molecule Drug Major Product Offerings
7.8.4 Roche Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Targeted Small Molecule Drug Major Product Offerings
7.9.4 Bristol-Myers Squibb Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Targeted Small Molecule Drug Major Product Offerings
7.10.4 Pfizer Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 BEACON Pharma
7.11.1 BEACON Pharma Company Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Targeted Small Molecule Drug Major Product Offerings
7.11.4 BEACON Pharma Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News & Latest Developments
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Company Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Targeted Small Molecule Drug Major Product Offerings
7.12.4 Jiangxi Shanxiang Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News & Latest Developments
7.13 Yao Pharma
7.13.1 Yao Pharma Company Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Targeted Small Molecule Drug Major Product Offerings
7.13.4 Yao Pharma Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News & Latest Developments
7.14 CSPC
7.14.1 CSPC Company Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Targeted Small Molecule Drug Major Product Offerings
7.14.4 CSPC Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News & Latest Developments
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Company Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Targeted Small Molecule Drug Major Product Offerings
7.15.4 CHIATAI Tianqing Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News & Latest Developments
7.16 Simcere
7.16.1 Simcere Company Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Targeted Small Molecule Drug Major Product Offerings
7.16.4 Simcere Targeted Small Molecule Drug Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Targeted Small Molecule Drug Market Opportunities & Trends in Global Market
Table 2. Targeted Small Molecule Drug Market Drivers in Global Market
Table 3. Targeted Small Molecule Drug Market Restraints in Global Market
Table 4. Key Players of Targeted Small Molecule Drug in Global Market
Table 5. Top Targeted Small Molecule Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Targeted Small Molecule Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Targeted Small Molecule Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Targeted Small Molecule Drug Product Type
Table 9. List of Global Tier 1 Targeted Small Molecule Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeted Small Molecule Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Targeted Small Molecule Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Targeted Small Molecule Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Targeted Small Molecule Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Targeted Small Molecule Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Targeted Small Molecule Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Targeted Small Molecule Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Targeted Small Molecule Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Targeted Small Molecule Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Targeted Small Molecule Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Targeted Small Molecule Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Targeted Small Molecule Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Targeted Small Molecule Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Targeted Small Molecule Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Targeted Small Molecule Drug Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Targeted Small Molecule Drug Product Offerings
Table 32. Bayer Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Eisai Company Summary
Table 35. Eisai Targeted Small Molecule Drug Product Offerings
Table 36. Eisai Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Eisai Key News & Latest Developments
Table 38. Zelgen Company Summary
Table 39. Zelgen Targeted Small Molecule Drug Product Offerings
Table 40. Zelgen Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Zelgen Key News & Latest Developments
Table 42. Cipla Company Summary
Table 43. Cipla Targeted Small Molecule Drug Product Offerings
Table 44. Cipla Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Cipla Key News & Latest Developments
Table 46. Natco Pharma Company Summary
Table 47. Natco Pharma Targeted Small Molecule Drug Product Offerings
Table 48. Natco Pharma Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Natco Pharma Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Targeted Small Molecule Drug Product Offerings
Table 52. AstraZeneca Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Targeted Small Molecule Drug Product Offerings
Table 56. Novartis Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Targeted Small Molecule Drug Product Offerings
Table 60. Roche Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Targeted Small Molecule Drug Product Offerings
Table 64. Bristol-Myers Squibb Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Targeted Small Molecule Drug Product Offerings
Table 68. Pfizer Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. BEACON Pharma Company Summary
Table 71. BEACON Pharma Targeted Small Molecule Drug Product Offerings
Table 72. BEACON Pharma Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 73. BEACON Pharma Key News & Latest Developments
Table 74. Jiangxi Shanxiang Company Summary
Table 75. Jiangxi Shanxiang Targeted Small Molecule Drug Product Offerings
Table 76. Jiangxi Shanxiang Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Jiangxi Shanxiang Key News & Latest Developments
Table 78. Yao Pharma Company Summary
Table 79. Yao Pharma Targeted Small Molecule Drug Product Offerings
Table 80. Yao Pharma Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Yao Pharma Key News & Latest Developments
Table 82. CSPC Company Summary
Table 83. CSPC Targeted Small Molecule Drug Product Offerings
Table 84. CSPC Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 85. CSPC Key News & Latest Developments
Table 86. CHIATAI Tianqing Company Summary
Table 87. CHIATAI Tianqing Targeted Small Molecule Drug Product Offerings
Table 88. CHIATAI Tianqing Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 89. CHIATAI Tianqing Key News & Latest Developments
Table 90. Simcere Company Summary
Table 91. Simcere Targeted Small Molecule Drug Product Offerings
Table 92. Simcere Targeted Small Molecule Drug Revenue (US$, Mn) & (2018-2023)
Table 93. Simcere Key News & Latest Developments
List of Figures
Figure 1. Targeted Small Molecule Drug Segment by Type in 2022
Figure 2. Targeted Small Molecule Drug Segment by Application in 2022
Figure 3. Global Targeted Small Molecule Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Targeted Small Molecule Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Targeted Small Molecule Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Targeted Small Molecule Drug Revenue in 2022
Figure 8. By Type - Global Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Targeted Small Molecule Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Targeted Small Molecule Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 16. US Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 20. Germany Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 28. China Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Targeted Small Molecule Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Targeted Small Molecule Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eisai Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Zelgen Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cipla Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Natco Pharma Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Roche Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BEACON Pharma Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jiangxi Shanxiang Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Yao Pharma Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CSPC Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. CHIATAI Tianqing Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Simcere Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

※参考情報

低分子標的薬は、特定の分子を標的とすることで、病気の原因や進行を抑制するための薬剤です。これらの薬剤は、通常、分子量が小さく、細胞を通過しやすいという特性を持っています。低分子標的薬は、主に癌治療や自己免疫疾患、感染症、代謝異常などの治療に用いられています。

低分子標的薬の第一の特徴は、特定の生理活性分子や細胞内シグナル伝達経路を選択的にターゲットとする点です。これにより、従来の抗がん剤などに比べ、副作用が少なく、治療効果が高いことが期待できます。この薬剤は、腫瘍細胞や病原体、炎症反応の原因となる細胞など特定の標的に対して高い選択性を持ち、正常細胞への影響を最小限に抑えることが可能です。

低分子標的薬の種類には、主に酵素阻害剤や受容体拮抗薬、細胞内シグナル伝達経路を調節する薬剤などがあります。酵素阻害剤は、特定の酵素の働きを阻害することにより、癌細胞の成長を抑制します。受容体拮抗薬は、特定の細胞受容体に結合し、その活性をブロックすることで、異常な細胞増殖を抑えたり、細胞死を誘導したりします。また、細胞内シグナル伝達経路調節薬は、特定のシグナル伝達経路を調節することで、細胞の生存や増殖に関与するシグナルをブロックします。

低分子標的薬は、様々な用途で使用されます。特に、悪性腫瘍の治療において重要な役割を果たしています。例えば、BRAF変異を有する悪性黒色腫に対して使用されるBRAF阻害剤や、EGFR変異を有する非小細胞肺癌に対するEGFR阻害剤などが存在します。これらの薬剤は、特定の遺伝子変異に基づいており、個別化医療の一環として患者に対して最適な治療を提供します。

低分子標的薬は、自身の免疫系を活性化させることによる効果も持ち合わせており、最近の研究では、これらの薬剤が免疫チェックポイント阻害剤との併用療法で期待されていることもあります。このような併用療法により、腫瘍の成長をより一層抑制することが可能となり、患者の生存率を向上させることが示唆されています。

関連技術としては、バイオマーカーの研究や新しい標的の同定が挙げられます。バイオマーカーは、特定の病気の存在や進行、治療効果の予測に用いられる生物学的指標です。これにより、低分子標的薬が最も効果的に作用する患者群を特定することが可能になります。また、新たな標的の同定は、従来の治療法では効果のなかった患者に希望をもたらす機会を提供します。

さらに、低分子標的薬の開発には、構造生物学やコンピュータ支援ドラッグデザイン（CADD）が重要な役割を果たします。これらの技術により、標的分子の構造を理解し、効果的な薬剤候補を迅速に発見することができます。これにより、従来よりも短期間で新薬の開発が可能となり、患者への治療を迅速に提供できるようになっています。

また、低分子標的薬は、さまざまな投与経路でも利用可能であり、経口薬や注射薬として使用できます。特に経口薬は、利便性が高く、患者の服薬コンプライアンスの向上にも寄与します。最近では、ナノテクノロジーの導入により、薬剤の標的部位への効果的なデリバリーが可能となり、副作用をさらに低減することが期待されています。

低分子標的薬の開発には、膨大な研究開発コストがかかるものの、その効果と安全性は多くの臨床試験によって証明されています。結果として、これらの薬剤は、医療分野において重要な治療オプションとなってきています。

今後の展望としては、さらなる精密医療の進展が期待されます。遺伝子解析技術の進歩により、個々の患者の遺伝子に基づいた、より個別化された治療が可能になることが見込まれています。また、AI（人工知能）技術を用いて新しい低分子標的薬の発見が加速する可能性もあり、より効率的な新薬開発が進むでしょう。

このように、低分子標的薬は、がん治療をはじめとするさまざまな疾患において重要な役割を果たしており、今後の医療の発展に大きく貢献することが期待されます。正確な標的に対する選択性や、個別化された治療を提供する可能性は、低分子標的薬の将来的な発展を大いに促進する要因となるでしょう。これにより、多くの患者にとって、より良い治療成果が得られることが期待されます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 低分子標的薬の世界市場見通し2023年-2029年(Targeted Small Molecule Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

低分子標的薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp